| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18126465
[patent_doc_number] => 20230012086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817239
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817239 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Aug 2, 2022 | Pending |
Array
(
[id] => 18056412
[patent_doc_number] => 20220387498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817276
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817276 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Aug 2, 2022 | Pending |
Array
(
[id] => 19700062
[patent_doc_number] => 12194061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/817207
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 138
[patent_figures_cnt] => 196
[patent_no_of_words] => 104260
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817207 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | Aug 2, 2022 | Issued |
Array
(
[id] => 18056411
[patent_doc_number] => 20220387497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817247
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817247 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Aug 2, 2022 | Pending |
Array
(
[id] => 18056413
[patent_doc_number] => 20220387499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817281
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817281 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | Aug 2, 2022 | Issued |
Array
(
[id] => 18056409
[patent_doc_number] => 20220387495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817226
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817226 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Aug 2, 2022 | Pending |
Array
(
[id] => 18144830
[patent_doc_number] => 20230018682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/874767
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874767 | METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY | Jul 26, 2022 | Pending |
Array
(
[id] => 18144830
[patent_doc_number] => 20230018682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/874767
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874767 | METHODS AND COMPOSITIONS OF NATURAL KILLER CELL ADOPTIVE TRANSFER THERAPY | Jul 26, 2022 | Pending |
Array
(
[id] => 19930339
[patent_doc_number] => 12303532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Combined organ and hematopoietic cells for transplantation tolerance of grafts
[patent_app_type] => utility
[patent_app_number] => 17/872741
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 37428
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872741 | Combined organ and hematopoietic cells for transplantation tolerance of grafts | Jul 24, 2022 | Issued |
Array
(
[id] => 18093143
[patent_doc_number] => 20220411484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS FOR TREATING VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/863149
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863149 | METHODS FOR TREATING VIRAL INFECTIONS | Jul 11, 2022 | Pending |
Array
(
[id] => 20227344
[patent_doc_number] => 12415987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Methods and composition for producing and using immune cells and stem cells for cell-based therapies
[patent_app_type] => utility
[patent_app_number] => 17/861534
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 15200
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861534 | Methods and composition for producing and using immune cells and stem cells for cell-based therapies | Jul 10, 2022 | Issued |
Array
(
[id] => 20227344
[patent_doc_number] => 12415987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Methods and composition for producing and using immune cells and stem cells for cell-based therapies
[patent_app_type] => utility
[patent_app_number] => 17/861534
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 15200
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861534 | Methods and composition for producing and using immune cells and stem cells for cell-based therapies | Jul 10, 2022 | Issued |
Array
(
[id] => 20227344
[patent_doc_number] => 12415987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Methods and composition for producing and using immune cells and stem cells for cell-based therapies
[patent_app_type] => utility
[patent_app_number] => 17/861534
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 15200
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17861534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/861534 | Methods and composition for producing and using immune cells and stem cells for cell-based therapies | Jul 10, 2022 | Issued |
Array
(
[id] => 17981182
[patent_doc_number] => 20220347218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => GENERATING CIK NKT CELLS FROM CORD BLOOD
[patent_app_type] => utility
[patent_app_number] => 17/856997
[patent_app_country] => US
[patent_app_date] => 2022-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856997 | Generating CIK NKT cells from cord blood | Jul 2, 2022 | Issued |
Array
(
[id] => 18077722
[patent_doc_number] => 20220403334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/810537
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810537 | Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy | Jun 30, 2022 | Issued |
Array
(
[id] => 18065681
[patent_doc_number] => 20220396768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/810540
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810540 | Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy | Jun 30, 2022 | Issued |
Array
(
[id] => 18034623
[patent_doc_number] => 20220378838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/856800
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856800
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856800 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | Jun 30, 2022 | Issued |
Array
(
[id] => 18345188
[patent_doc_number] => 20230133298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/856806
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856806 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Jun 30, 2022 | Pending |
Array
(
[id] => 18065682
[patent_doc_number] => 20220396769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/810542
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810542 | Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy | Jun 30, 2022 | Issued |
Array
(
[id] => 18141806
[patent_doc_number] => 20230015649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/856793
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 348
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856793 | PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY | Jun 30, 2022 | Pending |